Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
sector : Professional, scientific, and technical services crawled date : 2022 - 03 - 30 save search
Miromatrix Reports Fourth Quarter and Full Year 2021 Results and Provides Corporate Update
Published: 2022-03-30 (Crawled : 22:00) - biospace.com/
MIRO | $3.39 3.25% 630K
|
Professional, Scientific, and T...
|
| O: -0.27%
H: 6.98%
C: 1.89%
results
LianBio Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
Published: 2022-03-30 (Crawled : 21:00) - globenewswire.com
LIAN | $4.92 0.41% 0.41% 410K
|
Professional, Scientific, and T...
|
| O: 1.96%
H: 16.21%
C: 1.92%
results
Aerovate Therapeutics Announces Full-Year 2021 Financial Results
Published: 2022-03-30 (Crawled : 21:00) - globenewswire.com
AVTE M | $22.09 0.18% 0.18% 110K
|
Professional, Scientific, and T...
|
| O: 0.33%
H: 4.69%
C: 1.83%
therapeutics results
Prometheus Biosciences Initiates Third Phase 2 Study of PRA023 for Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD)
Published: 2022-03-30 (Crawled : 13:20) - biospace.com/
RXDX | $199.92 0.02% 1.9M
|
Professional, Scientific, and T...
|
| O: 0.34%
H: 1.67%
C: -3.47%
pra023 disease phase 2
Compass Therapeutics Announces Presentation on CTX-8371, A Bispecific Antibody Targeting PD-1 and PD-L1, at the 2022 AACR Annual Meeting in New Orleans
Published: 2022-03-30 (Crawled : 13:20) - biospace.com/
CMPX | $1.47 0.0% 110K
|
Professional, Scientific, and T...
|
| O: 0.79%
H: 10.24%
C: 4.72%
ctx-8371 antibody therapeutics presentation
Benzinga Listmakers - Top 24 EV & Allied Companies
Published: 2022-03-30 (Crawled : 13:20) - prnewswire.com
EMBK | $2.88 0.35% 0.17% 0
|
Professional, Scientific, and T...
|
| O: -0.65%
H: 3.42%
C: -2.44%
MULN | News | $2.535 -2.5% -2.56% 1.1M
|
Information
|
| O: -3.4%
H: 38.77%
C: 33.48%
WEJO | $0.045 11.11% 23M
|
n/a
|
| O: 0.24%
H: 1.2%
C: -2.65%
WKSP | $0.3702 -4.09% -4.27% 80K
|
Manufacturing
|
| O: 0.0%
H: 0.0%
C: -0.84%
LCID | $2.375 -3.06% -3.16% 20M
|
|
| O: -0.66%
H: 3.51%
C: -2.5%
FREY | $1.6 -1.23% 0.0% 860K
|
|
| O: 2.33%
H: 4.2%
C: 0.79%
KULR | $0.4464 -0.18% 0.81% 4.3M
|
Manufacturing
|
| O: -0.83%
H: 2.52%
C: -2.94%
F | News | $12.88 6.1% -0.04% 86M
|
Consumer Durables
|
| O: -1.3%
H: 0.8%
C: -1.43%
companies
Panamera Holdings Corporation Acquires Arsham Aluminum Alloys, LLC
Published: 2022-03-30 (Crawled : 12:20) - prnewswire.com
PHCI 4 | $0.9575 0% 200
|
Professional, Scientific, and T...
| Email alert
Add to watchlist
corporation
Eco Innovation's Next-Gen Cannabis Extraction Technology on Track for Full Commercial Launch as U.S. House Considers Federal Cannabis Legalization
Published: 2022-03-30 (Crawled : 12:20) - prnewswire.com
ECOX | $0.0002 0.0% 7M
|
Professional, Scientific, and T...
|
| O: 18.52%
H: 100.0%
C: 12.5%
cannabis technology commercialization
VectivBio Announces Japan License Deal and Loan Facility Agreement, Providing up to $117 Million to Fuel the Company Through Key Catalysts
Published: 2022-03-30 (Crawled : 12:20) - globenewswire.com
VECT | $16.85 0.12% 130K
|
Professional, Scientific, and T...
|
| O: -0.99%
H: 1.0%
C: 1.0%
deal license
UpHealth Announces Fourth Quarter and Full Year 2021 Financial Results
Published: 2022-03-30 (Crawled : 12:00) - prnewswire.com
UPH | $0.3 9.13% 0.0% 350K
|
Professional, Scientific, and T...
|
| O: -12.12%
H: 0.0%
C: -22.41%
results
Design Therapeutics Completes Dosing in First Patient Cohort of Phase 1 Trial of DT-216 GeneTAC™ Molecule for the Treatment of Friedreich Ataxia
Published: 2022-03-30 (Crawled : 11:00) - globenewswire.com
DSGN | $3.91 5.68% 5.37% 250K
|
Professional, Scientific, and T...
|
| O: -0.06%
H: 2.91%
C: -2.79%
dt-216 treatment trial therapeutics designation phase 1 friedreich’s ataxia
Liver Cancer Drugs Market - 42% of Growth to Originate from North America | Evolving Opportunities with AstraZeneca Plc & Bayer AG| 17000+ Technavio Reports
Published: 2022-03-30 (Crawled : 03:00) - prnewswire.com
AZNCF | News | $136.2 -4.19% 1.7K
|
Health Technology
|
| O: -5.22%
H: 6.2%
C: 1.91%
QBIO | $0.0002 100.0% 1.1K
|
Professional, Scientific, and T...
|
| O: 0.0%
H: 0.0%
C: -15.0%
NVS | News | $95.12 0.81% -1.18% 2.4M
|
Health Technology
|
| O: 0.58%
H: 0.56%
C: -0.07%
AZN | News | $70.12 2.29% 2.24% 4.8M
|
Health Technology
|
| O: 0.42%
H: 1.49%
C: 1.34%
america liver cancer growth market
Construction Management Software Size to Grow by USD 1.13 Bn| Increasing Requirements for Large-Scale Project Management to boost market growth| Technavio
Published: 2022-03-30 (Crawled : 02:00) - prnewswire.com
SGGEF | $14.59 -47.52% 330
|
Technology Services
|
| O: -3.44%
H: 0.0%
C: 0.0%
SGPYY | $57.14 3.25% 8.3K
|
Professional, Scientific, and T...
|
| O: 0.19%
H: 0.21%
C: -1.0%
PCOR | $70.58 0.41% 0.0% 990K
|
Information
|
| O: -1.33%
H: 0.79%
C: -3.48%
TRMB S | $58.91 1.62% 1.6% 860K
|
Electronic Technology
|
| O: -0.71%
H: 0.59%
C: -0.18%
management construction software market
First XP-V Patient Treated in Clinuvel DNA Repair Study
Published: 2022-03-29 (Crawled : 01:00) - clinuvel.com
CLVLY | $9.5 31.84% 2.5K
|
Professional, Scientific, and T...
|
| O: 1.08%
H: 0.48%
C: -1.23%
Gainers vs Losers
| 75% | 25% |
Top 10 Gainers
MTTR | News M | $4.78 174.71% 63.6% 72M
|
AGBA | $2.565 105.2% 51.27% 200M
|
Finance
MLEC | $2.44 74.29% 42.62% 78M
|
n/a
EDBL | News | $6.28 67.02% 40.13% 16M
|
ATGL | $2.91 48.81% 32.8% 180K
|
ZAPP | $0.2175 47.16% 32.05% 16M
|
n/a
ONFO | $0.6075 38.38% 27.74% 7.3M
|
n/a
VIVK | $1.48 38.32% 27.7% 530K
|
Professional, Scientific, and T...
MNTS | $0.5 35.69% 26.3% 4.8M
|
SDIG A | $3.635 35.13% 26.0% 1M
|
Your saved searches
Save your searches and get alerts when important news are released.